ArticleStem cell research & therapy2025
FFAR4 drives stem cell fate toward lipid- and iron-storing enterocytes protecting human enteroids from ferroptosis.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundIntestinal stem cell (ISC) fate is directed by microenvironmental cues, partly regulated through surface receptors, many of which remain incompletely characterized. Here, we investigated the functional role of the lipid-sensing receptor free fatty acid receptor 4 (FFAR4) in regulating ISC fate in normal-weight individuals, and hypothesized that its function may be affected in the lipid-rich environment of patients with obesity.
methodsHuman-derived small intestinal organoids (enteroids) were developed from normal-weight multi-organ donors and from patients with obesity who underwent a Roux-en Y gastric bypass.
resultsIn enteroids derived from normal-weight individuals, FFAR4 activation in ISCs promoted differentiation toward lipid-processing absorptive enterocytes while reducing secretory goblet cell formation. Functionally, mucin production was not affected but lipid droplet formation and iron storage were increased and blocked by a MEK1/2 inhibitor. This crosstalk reduced lipid peroxidation and hence the susceptibility to ferroptosis in the presence of environmental stressors. In contrast, FFAR4 activation in enteroids from patients with obesity failed to rewire the composition and function of the enteroid epithelium, suggesting impaired FFAR4 signaling in the obese ISC compartment.
conclusionsAltogether, our findings show that chemosensory receptors on stem cells play a more influential role than previously appreciated in modulating gut epithelial composition and function in response to environmental cues.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.